Highlights

  • Amazon, Flipkart among 20 e-tailors given notices for selling drugs without licence
  • Necessary action will be initiated against them in case of no reply

Latest news

From Toy Faces To Lucky Charms, DailyObjects’ New Cases Put Art On iPhones

From Toy Faces To Lucky Charms, DailyObjects’ New Cases Put Art On iPhones

Why Retirement Planning is Shifting From Wealth Accumulation to Income Sustainability

Why Retirement Planning is Shifting From Wealth Accumulation to Income Sustainability

OPPO 45W 20000mAh Power Bank Review: No Mess, Fast Speeds, Real Value 

OPPO 45W 20000mAh Power Bank Review: No Mess, Fast Speeds, Real Value 

One in Three Laptop Buyers Wants to Upgrade for AI; 24% Are Open to Snapdragon, Survey Finds

One in Three Laptop Buyers Wants to Upgrade for AI; 24% Are Open to Snapdragon, Survey Finds

Dell’s New Pro Headsets Offer AI Noise Reduction and Replaceable Batteries

Dell’s New Pro Headsets Offer AI Noise Reduction and Replaceable Batteries

Samsung’s AI Smart Glasses Launch On December 10 With Gemini, 12MP Camera

Samsung’s AI Smart Glasses Launch On December 10 With Gemini, 12MP Camera

Apple AirPods 5 Review: The Regular AirPods Are No Longer Basic

Apple AirPods 5 Review: The Regular AirPods Are No Longer Basic

Infinix GT 50 Pro Review: The Most Ambitious Phone Infinix Has Made

Infinix GT 50 Pro Review: The Most Ambitious Phone Infinix Has Made

Amazon, Flipkart among 20 e-tailors given notices for selling drugs without licence

The Drugs Controller General of India (DCGI) issued show-cause notices to Amazon, Flipkart Health plus among others over the online sale of drugs in violation of norms

Amazon, Flipkart among 20 e-tailors given notices for selling drugs without licence

Amazon and Flipkart Health plus are among the 20 online sellers that have been issued show-cause notices by the Drugs Controller General of India (DCGI) over the online sale of drugs in violation of norms.

The show-cause notice dated February 8 by DCGI V G Somani cited a Delhi High Court order dated December 12, 2018, which prohibits online sales of medicines without a licence.

The notice stated that the DCGI had forwarded the order to all state and Union Territories in May and November 2019 and again on February 3 for necessary action and compliance.

"In spite of the same, you are found to be engaged in such activities without a licence," the notice to the online medicine sellers said.

"...You are hereby asked to show cause within 2 days from the date of issue of this notice, why action shall not be taken against you for sale, or stock, or exhibit or offer for sale or distribution of drugs in contravention of the provisions of the Drugs and Cosmetics Act 1940 and rules made thereunder," the notice said.

The notice states that the sale or stock or exhibit or offer for sale or distribution of any drug requires a licence from the concerned state licensing authority and conditions of a licence are required to be complied with by the licence holders.

Frequently Asked Questions

Amazon and Flipkart Health plus are among the 20 online sellers that have been issued show-cause notices by the Drugs Controller General of India (DCGI).

ADVERTISEMENT

Up Next

Amazon, Flipkart among 20 e-tailors given notices for selling drugs without licence

Amazon, Flipkart among 20 e-tailors given notices for selling drugs without licence

Why Retirement Planning is Shifting From Wealth Accumulation to Income Sustainability

Why Retirement Planning is Shifting From Wealth Accumulation to Income Sustainability

How Does a Critical Illness Policy Work? Coverage, Claims & Benefits Explained

How Does a Critical Illness Policy Work? Coverage, Claims & Benefits Explained

Sensex Falls 252 Points, Nifty Slips as Crude Oil Tops $106

Sensex Falls 252 Points, Nifty Slips as Crude Oil Tops $106

Sensex Jumps Over 1,100 Points, Nifty Gains 1.6% as IT Stocks Rally

Sensex Jumps Over 1,100 Points, Nifty Gains 1.6% as IT Stocks Rally

Sensex falls 429 points, Nifty slips 173 points after RBI rate hike

Sensex falls 429 points, Nifty slips 173 points after RBI rate hike

ADVERTISEMENT

editorji-whatsApp

More videos

RBI raises repo rate by 25 bps to 5.50%, shifts policy towards tightening

RBI raises repo rate by 25 bps to 5.50%, shifts policy towards tightening

GST rates likely unchanged as 57th Council meeting focuses on reforms

GST rates likely unchanged as 57th Council meeting focuses on reforms

Sensex gains 685 points, Nifty rises 220 points to cross 22,700

Sensex gains 685 points, Nifty rises 220 points to cross 22,700

Sensex gains 473 points, Nifty rises 134 points as markets stage recovery

Sensex gains 473 points, Nifty rises 134 points as markets stage recovery

India To Grow 7% In FY27, Next Growth Phase Hinges On Infra, Deeper Capital Markets: S&P Global

India To Grow 7% In FY27, Next Growth Phase Hinges On Infra, Deeper Capital Markets: S&P Global

Sensex Falls 49 Points, Nifty Slips 96 As Selling Pressure Returns

Sensex Falls 49 Points, Nifty Slips 96 As Selling Pressure Returns

Sensex falls 243 points, Nifty slips 64 points as foreign outflows and crude prices weigh

Sensex falls 243 points, Nifty slips 64 points as foreign outflows and crude prices weigh

India launches anti-dumping probes into 7 Chinese products, including key pharma ingredients

India launches anti-dumping probes into 7 Chinese products, including key pharma ingredients

Sensex crashes 1,124 points, Nifty falls 1.56% as crude surges above $107

Sensex crashes 1,124 points, Nifty falls 1.56% as crude surges above $107

Sensex Rises 315 Points, Nifty Gains 77 as Markets Recover After Sharp Sell-Off

Sensex Rises 315 Points, Nifty Gains 77 as Markets Recover After Sharp Sell-Off

Editorji Technologies Pvt. Ltd. © 2022 All Rights Reserved.